Dr. White Discusses the Potential to Cure Patients With Metastatic Breast Cancer
Dr. Charles Perou | Distinguished Lectureship in Breast Cancer Research | SABCS 2022Подробнее
Dr. White Describes the BR-002 Trial in Breast CancerПодробнее
Dr. White on CNS Metastases in HER2+ Breast CancerПодробнее
Dr. Julia White on Determining Risk in Patients With Breast CancerПодробнее
Dr. White on Ablative Radiotherapy for Metastatic Breast CancerПодробнее
Dr. Krill-Jackson on the Potential Utility of Trastuzumab Deruxtecan in Metastatic Breast CancerПодробнее
Dr. White Discusses Exceptions in the Z11 TrialПодробнее
Dr. White on the BR-002 Trial in Breast CancerПодробнее
Dr. White on the Utility of Ablative Radiotherapy in Metastatic Breast CancerПодробнее
Potential and progress in targeting less common markers: HER2, BRAF, KRAS, MET, TRK, and RETПодробнее
Dr Chalasani on the Potential Utility of Eftilagimod Alpha in HER2–/HER2-Low Breast CancerПодробнее
Dr. Tripathy on Immunotherapy Potential in HER2-Positive Breast CancerПодробнее
Dr. Blackwell Discusses Tucatinib in HER2+ Breast CancerПодробнее
KEYNOTE-522 Demonstrates Potential for Immunotherapy in Triple-Negative Breast CancerПодробнее
Potential treatment approaches for breast cancer with brain metastasesПодробнее
First-Line ER-Positive Metastatic Breast Cancer TreatmentsПодробнее
Dr. Tolaney on Sequencing Strategies in Metastatic HER2+ Breast CancerПодробнее
Treatment With Eribulin in Metastatic Breast CancerПодробнее
Dr. Geyer Discusses Challenges in HER2-Positive Metastatic Breast Cancer ManagementПодробнее
BRCA-related breast cancer: the implications of genetic testing and potential management optionsПодробнее
Changing Treatment Landscape in Metastatic Breast CancerПодробнее
